-
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group, 1 Dec 2023, In: The Lancet Diabetes and Endocrinology. 11, 12, p. 905-914Research output: Contribution to journal › Article › Academic › peer-review
- All publications